A Review of Current Diagnosis Strategies and Treatment Options for Major Depressive Disorder.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c69791) has announced the addition of Disease and Therapy Review: Major Depressive Disorder to their offering.

The Major Depressive Disorder Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments, including SSRIs and atypical antidepressants, tricyclic antidepressants, monoamine oxidase inhibitors, and non-drug therapies. Dosing information and treatment costs are provided for a wide range of products. General information is included on the size of the US market for SSRIs.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Report Overview

I. OVERVIEW

II. INCIDENCE AND PREVALENCE

Incidence Table: (Worldwide)

Prevalence Table: (US, Canada, UK, France, Germany, Spain, Japan, China, Mexico, Worldwide)

III. DIAGNOSIS

IV. TREATMENT

SSRIs and Atypical Antidepressants

Tricyclic Antidepressants

Monoamine Oxidase Inhibitors

Electroconvulsive Therapy

Phototherapy

Experimental Treatments

Psychological

Social

V. DOSING AND TREATMENT COSTS

VI MARKET SIZE

VII. COMMENTS

VIII. REFERENCES/RESOURCES

For more information visit http://www.researchandmarkets.com/reports/c69791